For cosmetic companies operating in North America, navigating regulatory differences between Canada and the United States is not just a technical exercise; it’s a strategic necessity. While both countries aim to ensure product safety, their approaches to ingredient restrictions differ.
Understanding how Health Canada’s Cosmetic Ingredient Hotlist compares to the framework enforced by the U.S. Food and Drug Administration (FDA) is essential for avoiding compliance risks, reformulation delays, and costly market entry barriers.
Regulatory Framework Overview
Canada: The Cosmetic Ingredient Hotlist Approach
In Canada, cosmetics are regulated under the Food and Drugs Act and the Cosmetic Regulations. A central tool used by regulators and industry alike is the Cosmetic Ingredient Hotlist.
Despite its importance, the Hotlist is not a law. Instead, it is an administrative tool that communicates substances that may:
- Violate the general safety provisions of the Act
- Require specific restrictions to be considered safe
The Hotlist is divided into two main categories:
- Prohibited ingredients: Substances not permitted in cosmetics under any condition
- Restricted ingredients: Substances allowed only under defined conditions (e.g. concentration limits, product type, mandatory warnings)
In practice, the Hotlist functions as a de facto regulatory standard, as non-compliance can lead to enforcement action.
United States: FDA Prohibited & Restricted Ingredients
In contrast, the United States takes a more minimalistic and legally defined approach under the Federal Food, Drug, and Cosmetic Act. The FDA maintains a short list of explicitly prohibited or restricted ingredients, which is legally enforceable.
Historically, the U.S. system has relied heavily on manufacturer responsibility for ensuring product safety prior to marketing. However, recent updates under the Modernization of Cosmetics Regulation Act (MoCRA) are gradually increasing regulatory oversight, including:
- Mandatory facility registration
- Adverse event reporting
- Safety substantiation requirements
Even with these changes, the U.S. still maintains far fewer explicit ingredient restrictions compared to Canada.
Practical Implications for Cosmetic Companies
For companies looking to sell in both markets, these differences create several operational challenges:
- Formulation Constraints
Products formulated for the U.S. market may not automatically comply with Canadian requirements. Common issues include:
- Exceeding Canadian concentration limits
- Use of ingredients restricted or prohibited in Canada
- Labeling Requirements
Canada often requires specific risk statements or cautionary labeling for certain ingredients, which are not required in the U.S.
- Regulatory Burden
- Canada requires Cosmetic Notification Forms (CNFs) within 10 days of first sale
- The U.S. has historically had no pre-market notification requirement (though MoCRA introduces new obligations)
- Dual Compliance Strategy
Companies may need to:
- Maintain two formulations or
- Formulate to the stricter Canadian standard to streamline compliance
Overall, Canada’s system is more prescriptive and precautionary, offering clearer direction but imposing stricter requirements. The United States remains more flexible, though it is evolving toward greater oversight with recent legislative changes.
For cosmetic brands, success in both markets depends on understanding these differences early and embedding regulatory strategy into product development; not treating it as a final checkpoint.
Blog Author

Madelyn Martinez
Madelyn graduated from the University of Toronto with an Honours Bachelor of Science, specializing in Human Biology-Health and Disease. Shortly after, she began her career in regulatory consulting, honing the skills needed to thrive in this field. She also earned a Certification in Food Policy and Regulatory Affairs from the University of Ottawa, focusing on the regulations and policies in public health, food, and nutrition.
